Rahway, New Jersey Thursday, November 20, 2025, 14:00 Hrs [IST] ...
Visa sees solid volume growth and cross-border gains, while Merck and Southern Company navigate competitive and regulatory ...
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...
One of the teams is trying to combine mRNA vaccine with ultrasound technology to treat deadly pancreatic cancer.
Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...
Zacks Investment Research on MSN
Here's Why Merck (MRK) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...
Investor's Business Daily on MSN
Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.
Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...
14hon MSN
Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?
Over the past two years, Merck ( MRK 0.19%) has faced several challenges, resulting in a decline in the company's share price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback